Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Ann+Hum+Genet 2016 ; 80 (1): 50-62 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
New Mutations Associated with Rasopathies in a Central European Population and Genotype-Phenotype Correlations #MMPMID26607044
Ann Hum Genet 2016[Jan]; 80 (1): 50-62 PMID26607044show ga
We performed the genetic analysis of Rasopathy syndromes in patients from Central European by direct sequencing followed by next generation sequencing of genes associated with Rasopathies. All 51 patients harboured the typical features of Rasopathy syndromes. Thirty-five mutations were identified in the examined patients (22 in PTPN11, two in SOS1, one in RIT1, one in SHOC2, two in HRAS, three in BRAF, two in MAP2K1 and two in the NF1 gene). Two of them (p.Gly392Glu in the BRAF gene and p.Gln164Lys in the MAP2K1 gene) were novel with a potentially pathogenic effect on the structure of these proteins. Statistically significant differences in the presence of pulmonary stenosis (63.64% vs. 23.81%, P = 0.013897) and cryptorchidism (76.47% vs. 30%, P = 0.040224) were identified as the result of comparison of the prevalence of phenotypic features in patients with the phenotype of Noonan syndrome and mutation in the PTPN11 gene, with the prevalence of the same features in patients without PTPN11 mutation. Cryptorchidism as a statistically significant feature in our patients with PTPN11 mutation was not reported as significant in other European countries (Germany, Italy and Greece). The majority of mutations were clustered in exons 3 (45.45%), 8 (22.73%), and 13 (22.73%) of the PTPN11 gene.
|*DNA Mutational Analysis[MESH]
|Adolescent[MESH]
|Adult[MESH]
|Child[MESH]
|Child, Preschool[MESH]
|Cryptorchidism/*genetics[MESH]
|Ectodermal Dysplasia/genetics[MESH]
|Exons[MESH]
|Facies[MESH]
|Failure to Thrive/genetics[MESH]
|Female[MESH]
|Heart Defects, Congenital/genetics[MESH]
|Humans[MESH]
|Infant[MESH]
|Intracellular Signaling Peptides and Proteins/genetics[MESH]
|Male[MESH]
|Noonan Syndrome/*genetics[MESH]
|Phenotype[MESH]
|Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics[MESH]